Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 May;73(5):1249–1253. doi: 10.1172/JCI111326

Surface-mediated defense reactions. The plasma contact activation system.

R W Colman
PMCID: PMC425145  PMID: 6371055

Full text

PDF
1249

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alving B. M., Hojima Y., Pisano J. J., Mason B. L., Buckingham R. E., Jr, Mozen M. M., Finlayson J. S. Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction. N Engl J Med. 1978 Jul 13;299(2):66–70. doi: 10.1056/NEJM197807132990203. [DOI] [PubMed] [Google Scholar]
  2. Bagdasarian A., Colman R. W. Subcellular localization and purification of platelet alpha1-antitrypsin. Blood. 1978 Jan;51(1):139–156. [PubMed] [Google Scholar]
  3. Busch G. J., Kobayashi K., Hollenberg N. K., Birtch A. G., Colman R. W. Hyperacute renal allograft rejection in the primate. Intrarenal effects of heparin and associated net release of factor VIII activity and kallikrein activation. Am J Pathol. 1975 Jul;80(1):1–20. [PMC free article] [PubMed] [Google Scholar]
  4. Carvalho A. C., Lees R. S., Vaillancourt R. A., Colman R. W. Effect of clofibrate on intravascular coagulation in hyperlipoproteinemia. Circulation. 1977 Jul;56(1):114–118. doi: 10.1161/01.cir.56.1.114. [DOI] [PubMed] [Google Scholar]
  5. Colman R. W. Activation of plasminogen by human plasma kallikrein. Biochem Biophys Res Commun. 1969 Apr 29;35(2):273–279. doi: 10.1016/0006-291x(69)90278-2. [DOI] [PubMed] [Google Scholar]
  6. Colman R. W., Edelman R., Scott C. F., Gilman R. H. Plasma kallikrein activation and inhibition during typhoid fever. J Clin Invest. 1978 Feb;61(2):287–296. doi: 10.1172/JCI108938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Colman R. W., Wong P. Y. Participation of Hageman factor dependent pathways in human disease states. Thromb Haemost. 1977 Dec 15;38(4):751–775. [PubMed] [Google Scholar]
  8. Fujikawa K., Heimark R. L., Kurachi K., Davie E. W. Activation of bovine factor XII (Hageman factor) by plasma kallikrein. Biochemistry. 1980 Apr 1;19(7):1322–1330. doi: 10.1021/bi00548a010. [DOI] [PubMed] [Google Scholar]
  9. Ghebrehiwet B., Silverberg M., Kaplan A. P. Activation of the classical pathway of complement by Hageman factor fragment. J Exp Med. 1981 Mar 1;153(3):665–676. doi: 10.1084/jem.153.3.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gjonnaess H. Cold promoted activation of factor VII. I. Evidence for the existence of an activator. Thromb Diath Haemorrh. 1972 Oct 31;28(2):155–168. [PubMed] [Google Scholar]
  11. Goldsmith G. H., Jr, Saito H., Ratnoff O. S. The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments. J Clin Invest. 1978 Jul;62(1):54–60. doi: 10.1172/JCI109113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gordon E. M., Ratnoff O. D., Saito H., Donaldson V. H., Pensky J., Jones P. K. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives. J Lab Clin Med. 1980 Nov;96(5):762–769. [PubMed] [Google Scholar]
  13. Kaplan A. P., Kay A. B., Austen K. F. A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J Exp Med. 1972 Jan;135(1):81–97. doi: 10.1084/jem.135.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kluft C. Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein. J Lab Clin Med. 1978 Jan;91(1):83–95. [PubMed] [Google Scholar]
  15. Lahiri B., Bagdasarian A., Mitchell B., Talamo R. C., Colman R. W. Antithrombin-heparin cofactor: an inhibitor of plasma kallikrein. Arch Biochem Biophys. 1976 Aug;175(2):737–747. doi: 10.1016/0003-9861(76)90567-1. [DOI] [PubMed] [Google Scholar]
  16. Lange L. G., 3rd, Carvalho A., Bagdasarian A., Lahiri B., Colman R. W. Activation of Hageman factor in the nephrotic syndrome. Am J Med. 1974 Apr;56(4):565–569. doi: 10.1016/0002-9343(74)90490-2. [DOI] [PubMed] [Google Scholar]
  17. Lewin M. F., Kaplan A. P., Harpel P. C. Studies of C1 inactivator-plasma kallikrein complexes in purified systems and in plasma. J Biol Chem. 1983 May 25;258(10):6415–6421. [PubMed] [Google Scholar]
  18. MARGOLIS J. The interrelationship of coagulation of plasma and release of peptides. Ann N Y Acad Sci. 1963 Feb 4;104:133–145. doi: 10.1111/j.1749-6632.1963.tb17659.x. [DOI] [PubMed] [Google Scholar]
  19. Mandle R. J., Colman R. W., Kaplan A. P. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc Natl Acad Sci U S A. 1976 Nov;73(11):4179–4183. doi: 10.1073/pnas.73.11.4179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mandle R. J., Jr, Kaplan A. P. Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen. Blood. 1979 Oct;54(4):850–862. [PubMed] [Google Scholar]
  21. Mason J. W., Colman R. W. The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia, or liver disease. Thromb Diath Haemorrh. 1971 Oct 31;26(2):325–331. [PubMed] [Google Scholar]
  22. Mason J. W., Kleeberg U., Dolan P., Colman R. W. Plasma kallikrein and Hageman factor in Gram-negative bacteremia. Ann Intern Med. 1970 Oct;73(4):545–551. doi: 10.7326/0003-4819-73-4-545. [DOI] [PubMed] [Google Scholar]
  23. Newball H. H., Berninger R. W., Talamo R. C., Lichtenstein L. M. Anaphylactic release of a basophil kallikrein-like activity. I. Purification and characterization. J Clin Invest. 1979 Aug;64(2):457–465. doi: 10.1172/JCI109483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Newball H. H., Meier H. L., Kaplan A. P., Revak S. D., Cochrane C. G., Lichtenstein L. M. Activation of Hageman factor by proteases released during antigen challenge of human lung. Trans Assoc Am Physicians. 1981;94:126–133. [PubMed] [Google Scholar]
  25. Nies A. S., Forsyth R. P., Williams H. E., Melmon K. L. Contribution of kinins to endotoxin shock in unanesthetized Rhesus monkeys. Circ Res. 1968 Feb;22(2):155–164. doi: 10.1161/01.res.22.2.155. [DOI] [PubMed] [Google Scholar]
  26. Niewiarowski S., Bańkowski E., Rogowicka I. Studies on the adsorption and activation of the Hageman factor (factor XII) by collagen and elastin. Thromb Diath Haemorrh. 1965 Nov 15;14(3-4):387–400. [PubMed] [Google Scholar]
  27. Osterud B., Rapaport S. I. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5260–5264. doi: 10.1073/pnas.74.12.5260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Plow E. F. Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway. J Clin Invest. 1982 Mar;69(3):564–572. doi: 10.1172/JCI110482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Proud D., Togias A., Naclerio R. M., Crush S. A., Norman P. S., Lichtenstein L. M. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest. 1983 Nov;72(5):1678–1685. doi: 10.1172/JCI111127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. RAPAPORT S. I., AAS K., OWREN P. A. The effect of glass upon the activity of the various plasma clotting factors. J Clin Invest. 1955 Jan;34(1):9–19. doi: 10.1172/JCI103067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Radcliffe R., Bagdasarian A., Colman R., Nemerson Y. Activation of bovine factor VII by hageman factor fragments. Blood. 1977 Oct;50(4):611–617. [PubMed] [Google Scholar]
  32. Radcliffe R., Nemerson Y. Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa. J Biol Chem. 1976 Aug 25;251(16):4749–4802. [PubMed] [Google Scholar]
  33. Rebuck J. W. The skin window as a monitor of leukocytic functions in contact activation factor deficiencies in man. Am J Clin Pathol. 1983 Apr;79(4):405–413. doi: 10.1093/ajcp/79.4.405. [DOI] [PubMed] [Google Scholar]
  34. Schapira M., Despland E., Scott C. F., Boxer L. A., Colman R. W. Purified human plasma kallikrein aggregates human blood neutrophils. J Clin Invest. 1982 May;69(5):1199–1202. doi: 10.1172/JCI110557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Schapira M., Scott C. F., Colman R. W. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. J Clin Invest. 1982 Feb;69(2):462–468. doi: 10.1172/JCI110470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Schapira M., Scott C. F., Colman R. W. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen. Biochemistry. 1981 May 12;20(10):2738–2743. doi: 10.1021/bi00513a006. [DOI] [PubMed] [Google Scholar]
  37. Schapira M., Scott C. F., James A., Silver L. D., Kueppers F., James H. L., Colman R. W. High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors. Biochemistry. 1982 Feb 2;21(3):567–572. doi: 10.1021/bi00532a024. [DOI] [PubMed] [Google Scholar]
  38. Schmaier A. H., Zuckerberg A., Silverman C., Kuchibhotla J., Tuszynski G. P., Colman R. W. High-molecular weight kininogen. A secreted platelet protein. J Clin Invest. 1983 May;71(5):1477–1489. doi: 10.1172/JCI110901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Schreiber A. D., Kaplan A. P., Austen K. F. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation. J Clin Invest. 1973 Jun;52(6):1402–1409. doi: 10.1172/JCI107313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Scott C. F., Colman R. W. Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma. J Clin Invest. 1980 Feb;65(2):413–421. doi: 10.1172/JCI109684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Scott C. F., Schapira M., Colman R. W. Effect of heparin on the inactivation rate of human factor XIa by antithrombin-III. Blood. 1982 Oct;60(4):940–947. [PubMed] [Google Scholar]
  42. Scott C. F., Schapira M., James H. L., Cohen A. B., Colman R. W. Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen. J Clin Invest. 1982 Apr;69(4):844–852. doi: 10.1172/JCI110524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Scott C. F., Silver L. D., Schapira M., Colman R. W. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor. J Clin Invest. 1984 Apr;73(4):954–962. doi: 10.1172/JCI111319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sealey J. E., Atlas S. A., Laragh J. H., Silverberg M., Kaplan A. P. Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5914–5918. doi: 10.1073/pnas.76.11.5914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Silverberg M., Dunn J. T., Garen L., Kaplan A. P. Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate. J Biol Chem. 1980 Aug 10;255(15):7281–7286. [PubMed] [Google Scholar]
  46. Silverberg M., Nicoll J. E., Kaplan A. P. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor. Thromb Res. 1980 Oct 15;20(2):173–189. doi: 10.1016/0049-3848(80)90383-7. [DOI] [PubMed] [Google Scholar]
  47. Smith P. L., Kagey-Sobotka A., Bleecker E. R., Traystman R., Kaplan A. P., Gralnick H., Valentine M. D., Permutt S., Lichtenstein L. M. Physiologic manifestations of human anaphylaxis. J Clin Invest. 1980 Nov;66(5):1072–1080. doi: 10.1172/JCI109936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Thompson R. E., Mandle R., Jr, Kaplan A. P. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain. Proc Natl Acad Sci U S A. 1979 Oct;76(10):4862–4866. doi: 10.1073/pnas.76.10.4862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Tuszynski G. P., Bevacqua S. J., Schmaier A. H., Colman R. W., Walsh P. N. Factor XI antigen and activity in human platelets. Blood. 1982 Jun;59(6):1148–1156. [PubMed] [Google Scholar]
  50. Wachtfogel Y. T., Kucich U., James H. L., Scott C. F., Schapira M., Zimmerman M., Cohen A. B., Colman R. W. Human plasma kallikrein releases neutrophil elastase during blood coagulation. J Clin Invest. 1983 Nov;72(5):1672–1677. doi: 10.1172/JCI111126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Walsh P. N., Griffin J. H. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI. Blood. 1981 Jan;57(1):106–118. [PubMed] [Google Scholar]
  52. Walsh P. N. The effects of collagen and kaolin on the intrinsic coagulant activity of platelets. Evidence for an alternative pathway in intrinsic coagulation not requiring factor XII. Br J Haematol. 1972 Apr;22(4):393–405. doi: 10.1111/j.1365-2141.1972.tb05687.x. [DOI] [PubMed] [Google Scholar]
  53. Wiggins R. C., Giclas P. C., Henson P. M. Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit. J Exp Med. 1981 Jun 1;153(6):1391–1404. doi: 10.1084/jem.153.6.1391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Wiggins R. C. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein. J Biol Chem. 1983 Jul 25;258(14):8963–8970. [PubMed] [Google Scholar]
  55. Wong P. Y., Talamo R. C., Babior B. M., Raymond G. G., Colman R. W. Kallikrein-kinin system in postgastrectomy dumping syndrome. Ann Intern Med. 1974 May;80(5):577–581. doi: 10.7326/0003-4819-80-5-577. [DOI] [PubMed] [Google Scholar]
  56. Wong P. Y., Williams G. H., Colman R. W. Studies on the renin-angiotensin system in a kininogen-deficient individual. Clin Sci (Lond) 1983 Aug;65(2):121–126. doi: 10.1042/cs0650121. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES